Alexander Sternjak

Title: Alexander Sternjak: Innovator in Antibody Constructs

Introduction

Alexander Sternjak is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibody constructs. His work focuses on innovative solutions that have the potential to impact medical applications.

Latest Patents

Sternjak holds a patent for MAGEB2 binding constructs. This invention relates to antibody constructs that comprise a domain binding to a MAGEB2 peptide complexed with an HLA, and optionally, another domain that binds to CD3. The patent also includes polynucleotides encoding these antibody constructs, vectors containing said polynucleotides, and host cells transformed or transfected with these polynucleotides or vectors. Additionally, the invention outlines processes for producing the antibody constructs, their medical uses, and kits that include these constructs. He has 1 patent to his name.

Career Highlights

Throughout his career, Sternjak has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has allowed him to contribute to cutting-edge research and development in the field.

Collaborations

Sternjak has collaborated with several professionals in his field, including Ian Nevin Foltz and Weihsu Claire Chen. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Alexander Sternjak is a distinguished inventor whose work in antibody constructs showcases his innovative spirit and dedication to advancing medical technology. His contributions are poised to make a significant difference in the field of biotechnology.